Chinese scientists have developed a unique artificial intelligence tool for neurosurgeons named “CARES Copilot 1.0.” This development signifies a burgeoning interest in the application of artificial intelligence within the medical field, where AI is increasingly utilized for diagnosing and treating diseases. In a bid to advance further in this domain, China is positioning itself at the forefront.
A team from the Chinese Academy of Sciences has crafted this new AI tool, drawing upon the architecture of Meta’s AI model, Llama 2.0. Tailored specifically to aid neurosurgeons, “CARES Copilot 1.0” is designed to act as a supportive assistant for medical practitioners.
It is slated for initial trials across seven different hospitals in China. Should these trials prove successful, the deployment of artificial intelligence in medical practices is expected to expand nationwide.
So what exactly will CARES Copilot 1.0 do?
CARES Copilot 1.0 has undergone training with over one million medical articles, enabling it to respond to queries from neurosurgeons. Additionally, it is capable of analyzing imaging techniques such as MRI, ultrasound, or CT scans. This artificial intelligence will assist neurosurgeons in diagnosing diseases and during surgical procedures. CARES Copilot 1.0 is adept at processing both text and voice inputs.
The AI, built on the Llama 2.0 model, is notably powerful, having been trained using approximately 100 GPUs—half of which were NVIDIA A100s and the other half Huawei Ascend 910Bs. It’s important to note the context of embargoes between China and the USA, which has restricted Chinese scientists’ access to NVIDIA technologies.
You may also like this content
- Samsung Introduces Gauss2: A Revolutionary Generative AI Model Enhancing Galaxy AI Experience
- GPT-4o, the brainchild of ChatGPT, has been Updated
- OpenAI’s AI Course for Educators Sparks Privacy and Security Concerns
-
-
-
-
-
-
-
-
-
-
